A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

Completed

Plain-English translation of NCT05033080 on ClinicalTrials.gov ↗ · Source last updated October 2024 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(139 sites)

United States

University of Alabama at Birmingham, Birmingham, Alabama

Banner University of Arizona Medical Center, Tucson, Arizona

Arkansas Children's Hospital, Little Rock, Arkansas

Miller Children's Hospital / Long Beach Memorial, Long Beach, California

Children's Hospital Los Angeles, Los Angeles, California